These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 30852955)
21. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia. Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447 [TBL] [Abstract][Full Text] [Related]
22. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Hohenberger P; Schlag PM; Gerneth T; Herfarth C Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484 [TBL] [Abstract][Full Text] [Related]
23. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial. Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I; Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037 [TBL] [Abstract][Full Text] [Related]
24. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer. Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077 [TBL] [Abstract][Full Text] [Related]
25. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients. Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586 [TBL] [Abstract][Full Text] [Related]
26. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres. Baqar AR; Wilkins S; Staples M; Angus Lee CH; Oliva K; McMurrick P Int J Surg; 2019 Apr; 64():10-15. PubMed ID: 30822523 [TBL] [Abstract][Full Text] [Related]
27. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases. Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497 [TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis. Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715 [TBL] [Abstract][Full Text] [Related]
29. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850 [TBL] [Abstract][Full Text] [Related]
30. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA. Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210 [TBL] [Abstract][Full Text] [Related]
31. CEA as a prognostic index in colorectal cancer. Forones NM; Tanaka M; Falcão JB Sao Paulo Med J; 1997; 115(6):1589-92. PubMed ID: 9640796 [TBL] [Abstract][Full Text] [Related]
32. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma. Veingerl B Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618 [TBL] [Abstract][Full Text] [Related]
33. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence. Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T Oncology; 2017; 92(5):276-282. PubMed ID: 28178692 [TBL] [Abstract][Full Text] [Related]
34. Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important? Filiz AI; Sucullu I; Kurt Y; Karakas DO; Gulec B; Akin ML Clinics (Sao Paulo); 2009; 64(4):287-94. PubMed ID: 19488584 [TBL] [Abstract][Full Text] [Related]
35. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients. Choi JS; Min JS Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477 [TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer. Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733 [TBL] [Abstract][Full Text] [Related]
37. Clinical Significance of the Post/Preoperative Anti-p53 Antibody Ratio in Predicting the Prognosis of Patients with Colorectal Cancer after Curative Surgery and Its Usefulness in Combination with Carcinoembryonic Antigen. Numata K; Shiozawa M; Ono Y; Iguchi K; Uchiyama M; Asari M; Rino Y; Saito A Oncology; 2024; 102(10):841-849. PubMed ID: 38382488 [TBL] [Abstract][Full Text] [Related]
38. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486 [TBL] [Abstract][Full Text] [Related]
39. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511 [TBL] [Abstract][Full Text] [Related]
40. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer. Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]